Kineta, Inc. (KA) 是一家上市公司 属于 医疗保健 板块，经营于 生物科技 行业. 公司总部位于 Seattle, WA, 美国. 现任CEO为 Craig W. Philips.
KA 拥有 IPO日期为 2016-02-11, 11 名全职员工, 在 NASDAQ Capital Marke, 市值为 $7.05M.
Kineta, Inc., a clinical stage biotechnology company, develops immunotherapies for oncology, neuroscience, and biodefense. It serves private, government, and industry partners. The company has strategic partnerships with Pfizer, Genentech, Wellcome, and Samsung Biologics Co., Ltd. Kineta, Inc. was formerly known as Lecura, Inc. The company was incorporated in 2007 and is based in Seattle, Washington.
